Results 121 to 130 of about 134,889 (183)

<i>In vivo</i> evolution of resistance to contemporary β-lactam/β-lactamase inhibitor combinations during treatment of a KPC-producing <i>Serratia marcescens</i> infection. [PDF]

Antimicrob Agents Chemother
Bailey DC, Castañeda-Barba S, Barry KE, Treerat P, Crawford MA, Hughes MA, Mathers AJ.   +6 more
europepmc   +1 more source

VII. Emerging and Re-emerging Infections Diseases

Nihon Naika Gakkai Zasshi, 2018
openaire   +2 more sources

Efficacy and Safety of Biosimilar AVT05 Versus Reference Product Golimumab in Combination with Methotrexate in Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results of a Randomized, Parallel-Group, Double-Blind Study. [PDF]

BioDrugs
Luque M, Zhelyazkova K, Vashishta L, Rai M, Sattar A, Petrovic K, Bucknall R, Leutz S, Berti F.   +8 more
europepmc   +1 more source

An Initial Single-Center European Experience with the Gore Thoracic Branch Endoprosthesis. [PDF]

Interdiscip Cardiovasc Thorac Surg
Dirven M, Geuzebroek GSC, Nauta FJH, van der Vijver RJ, Knaapen L, Geeraedts TEA, Jenniskens SFM, Heijmen RH.   +7 more
europepmc   +1 more source

Case Report: Fatal <i>Streptococcus pyogenes</i> infection secondary to closed femoral fracture. [PDF]

Front Med (Lausanne)
Zhong D, He J, Jin J, Pan Y.
europepmc   +1 more source

Total venous coronary artery bypass grafting for acute myocardial infarction with Leriche syndrome and porcelain aorta: a case report. [PDF]

J Surg Case Rep
Isa H, Shirakura K, Kawarabayashi T, Akamatsu H, Kagawa K, Miyatani K, Mochizuki N, Suzuki F, Ushioda R, Okubo R, Hirofuji A, Kunioka S, Tsutsui M, Kamiya H.   +13 more
europepmc   +1 more source

To face Disease X: building resilient futures in the age of emergent threats. [PDF]

BMJ Glob Health
Wu Z, Yao T, Shen N.
europepmc   +1 more source

Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment. [PDF]

Diabetes Care
DeFronzo RA, Fonseca V, Aroda VR, Auchus RJ, Bailey T, Bancos I, Busch RS, Buse JB, Christofides EA, Eilerman B, Findling JW, Handelsman Y, Kahn SE, Miller HJ, Ownby JG, Parker JC, Philis-Tsimikas A, Pratley R, Rosenstock J, Shanik MH, Sloan LA, Umpierrez G, Shambharkar S, Tudor IC, Schlafly TK, Einhorn D, CATALYST Investigators* .   +26 more
europepmc   +1 more source